WinstonWınston
Back
Regis Healthcare Limited logo

Regis Healthcare Limited

REG.AX
43
Medical - Care Facilities · Healthcare
Price
A$6.39
+0.01 (+0.16%)
Market Cap
A$1.93B
Exchange
Australian Securities Exchange
Winston Score
43
Winston is serious
Mixed quality — meaningful strengths and weaknesses.
Data as of Aug 23, 2026 · filings through Dec 31, 2025
How the score breaks down
Quality
Weak
Growth
Good
Cash Flow
Exceptional
Stability
Weak
Valuation
Good
Dividends
Strong

Winston Score History

The full picture

Regis Healthcare is one of Australia's largest aged care providers. It runs residential aged care homes — essentially nursing homes — where elderly Australians live and receive help with daily tasks, medical needs, and personal care. The company also offers home care services, helping older people stay in their own homes with support from trained staff.

Regis earns money through a mix of government funding and fees paid by residents and their families. It operates entirely within Australia, with facilities spread across most states. The business benefits from strong structural demand — Australia's population is aging, which means more people will need aged care services over time. However, the industry is heavily regulated by the federal government, which controls a large portion of the funding Regis receives. The main risk is that thin operating margins leave little room for error, and ongoing regulatory changes — including reforms following Australia's Royal Commission into Aged Care — could increase costs faster than revenue grows.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+10.8% YoY

YoY Growth Rate

Steady revenue growth

EPS Growth

+364.9% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

A$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

39.6%ownership

Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

A$316M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Growth + cash flow

Regis Healthcare Limited is a rare growth stock that's already generating positive cash flow while growing at 11%. The Winston Score doesn't fully credit this transition from "burner" to "earner."

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Share count broadly stable

+1.0% over 4y

The share count has stayed roughly flat over this period — little dilution or buyback activity.

Diluted shares outstanding: 300.9M (2021) → 303.9M (2025)

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
11.3%
Thin — 11.3% gross margin
Profit after running costs
Operating Margin
3.0%
Thin — 3.0% operating margin
Return on the money invested
ROCE
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+14.2%
Fast-growing sales (+14.2% YoY)
Profit growth
EPS YoY
+155.5%
Earnings growing fast (+155.5% YoY)

Earnings growing 25%+ a year. The compounder zone.

How steady the profit is
EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
1023%
Turns 1023% of profit into real cash
Spare cash per sale
FCF Margin
18.6%
Converts sales into free cash efficiently (18.6%)

FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
N/A
Data not available
Covers its interest
Interest Cover
0.28x
Dangerous — barely covers interest (0.3x)

Interest coverage below 1. Their profits don't cover the interest bill.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
50.6x
Expensive — P/E 50.6

P/E over 35. The market is pricing in heavy, sustained growth.

Cheaper or dearer next year
P/E vs Forward
+23.7
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (50.6 → 26.9)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
2.72%
Moderate income — 2.72% yield

Standard yield zone for stable dividend payers. A meaningful piece of total return.

Dividend record
Dividend Growth
+76.2%
Dividend growing fast (76.2% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial